Both in Pharmaceuticals
Acurx Pharmaceuticals vs Skye Bioscience
Over the past year ACXP returned −81.2% and SKYE returned −89.6%; their daily moves had a correlation of 0.04.
ACXP −81.2% SKYE −89.6%Growth of $1, one year, split-adjusted
| Metric | ACXP | SKYE |
|---|---|---|
| Price | $1.07 | $1.31 |
| Market cap | $5.9M | $5.8M |
| Today | 0.00% | −13.82% |
| 1 month | −15.1% | −18.6% |
| 6 months | −50.5% | −81.4% |
| Year to date | −57.0% | −78.2% |
| 1 year | −83.0% | −89.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.7M | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 60.1% | 617.6% |
| Short % of float | 1.8% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).